Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Activation of oxidative phosphorylation in TP53-inactive endometrial carcinomas with a poor prognosis.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Dec 2021

Takahashi Nobutaka, Hatakeyama Keiichi, Nagashima Takeshi, Ohshima Keiichi, Urakami Kenichi, Yamaguchi Ken, Hirashima Yasuyuki

Abstract excerpt

OBJECTIVE: We aimed to identify pathways for potential therapeutic targets by conducting molecular profiling of endometrial carcinomas in patients with poor prognosis. METHODS: The classification of endometrial carcinomas has undergone a paradigm shift with the advent of next generation sequencing based molecular profiling. Although this emerging classification reflects poor prognosis in patients with endometrial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Endometrioid
Share to Gene Expression Profiling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Oxidative Phosphorylation

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 34725206
DOI: 10.1136/ijgc-2021-002983

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Activation of oxidative phosphorylation in TP53-inactive endometrial carcinomas with a poor prognosis.PMID 34725206Read ↗

Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options.Semantic proximity Read ↗

Clinical Relevance of Oncogenic Driver Mutations Identified in Endometrial CarcinomaSemantic proximity Read ↗

Abnormal p53 expression is associated with poor outcomes in grade I or II, stage I, endometrioid carcinoma: a retrospective single-institute study.Semantic proximity Read ↗

Mutation frequencies in endometrial cancer patients of different ethnicities and tumor grades: An analytical studySemantic proximity Read ↗

Impact of TP53 somatic mutations on prognosis in endometrial cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.Semantic proximity Read ↗

Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas.Semantic proximity Read ↗

Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.Semantic proximity Read ↗

Potential new biomarkers for endometrial cancerSemantic proximity Read ↗

POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction.Semantic proximity Read ↗

Prognosis of polymerase epsilon (POLE) mutation in high-grade endometrioid endometrial cancer: Systematic review and meta-analysis.Semantic proximity Read ↗

Identification of NRAS Diagnostic Biomarkers and Drug Targets for Endometrial Cancer-An Integrated in Silico Approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.